相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology
Stephen J. Kaar et al.
NEUROPHARMACOLOGY (2020)
Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis
Yuya Mizuno et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
Robert A. McCutcheon et al.
WORLD PSYCHIATRY (2020)
A neuroimaging biomarker for striatal dysfunction in schizophrenia
Ang Li et al.
NATURE MEDICINE (2020)
The role of dopamine dysregulation and evidence for the transdiagnostic nature of elevated dopamine synthesis in psychosis: a positron emission tomography (PET) study comparing schizophrenia, delusional disorder, and other psychotic disorders
Pak Wing Calvin Cheng et al.
NEUROPSYCHOPHARMACOLOGY (2020)
The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography Study
Sameer Jauhar et al.
BIOLOGICAL PSYCHIATRY (2019)
Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study
Sameer Jauhar et al.
MOLECULAR PSYCHIATRY (2019)
Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain
Clifford M. Cassidy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models
Evangelia Christodoulou et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2019)
Receptor-Enriched Analysis of functional connectivity by targets (REACT): A novel, multimodal analytical approach informed by PET to study the pharmacodynamic response of the brain under MDMA
Ottavia Dipasquale et al.
NEUROIMAGE (2019)
The impact of switching to clozapine on psychiatric hospital admissions: a mirror-image study
P. Kirwan et al.
IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE (2019)
Stratified medicine in schizophrenia: how accurate would a test of drug response need to be to achieve cost-effective improvements in quality of life?
Huajie Jin et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2019)
Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis
Robert McCutcheon et al.
SCHIZOPHRENIA BULLETIN (2018)
Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia-A Nationwide Study With 20-Year Follow-up
Heidi Taipale et al.
SCHIZOPHRENIA BULLETIN (2018)
Delayed Initiation of Clozapine Continues to Be a Substantial Clinical Concern
Alexander Panickacheril John et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2018)
The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study
Sameer Jauhar et al.
LANCET PSYCHIATRY (2018)
Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study
Euitae Kim et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors
A. Demjaha et al.
PSYCHOLOGICAL MEDICINE (2017)
Regulation of dopaminergic function: an [18F]-DOPA PET apomorphine challenge study in humans
S. Jauhar et al.
TRANSLATIONAL PSYCHIATRY (2017)
The impact of clozapine on hospital use: a systematic review and meta-analysis
R. Land et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
Oliver D. Howes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia
Oliver D. Howes et al.
BIOLOGICAL PSYCHIATRY (2017)
Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive
Elias Mouchlianitis et al.
SCHIZOPHRENIA BULLETIN (2016)
Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia
T. Scott Stroup et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment
Deepak K. Sarpal et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
The Business Case for Expanded Clozapine Utilization
Jessica L. Goeren et al.
PSYCHIATRIC SERVICES (2016)
Adversity in childhood linked to elevated striatal dopamine function in adulthood
Alice Egerton et al.
SCHIZOPHRENIA RESEARCH (2016)
Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: A systematic review and meta-analysis
John Lally et al.
SCHIZOPHRENIA RESEARCH (2016)
NICE CG178 Psychosis and Schizophrenia in Adults: Treatment and Management - an evidence-based guideline?
Mark Taylor et al.
BRITISH JOURNAL OF PSYCHIATRY (2015)
Antipsychotic medication in schizophrenia: a review
John Lally et al.
BRITISH MEDICAL BULLETIN (2015)
Glutamate and dopamine in schizophrenia: An update for the 21st century
Oliver Howes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
The Promise of Biological Markers for Treatment Response in First-Episode Psychosis: A Systematic Review
Guillaume Fond et al.
SCHIZOPHRENIA BULLETIN (2015)
Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis
Valeria Mondelli et al.
SCHIZOPHRENIA BULLETIN (2015)
Antipsychotic Treatment Resistance in Schizophrenia Associated with Elevated Glutamate Levels but Normal Dopamine Function
Arsime Demjaha et al.
BIOLOGICAL PSYCHIATRY (2014)
White matter integrity as a predictor of response to treatment in first episode psychosis
Tiago Reis Marques et al.
BRAIN (2014)
Towards better clinical prediction models: seven steps for development and an ABCD for validation
Ewout W. Steyerberg et al.
EUROPEAN HEART JOURNAL (2014)
The social and economic burden of treatment-resistant schizophrenia: a systematic literature review
James L. Kennedy et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2014)
The need for a behavioural science focus in research on mental health and mental disorders
Hans-Ulrich Wittchen et al.
INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH (2014)
Schizophrenia: an integrated sociodevelopmental-cognitive model
Oliver D. Howes et al.
LANCET (2014)
Ventral Tegmental Area/Midbrain Functional Connectivity and Response to Antipsychotic Medication in Schizophrenia
Jennifer A. Hadley et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort
Alice Egerton et al.
BIOLOGICAL PSYCHIATRY (2013)
Dopaminergic Function in the Psychosis Spectrum: An [18F]-DOPA Imaging Study in Healthy Individuals With Auditory Hallucinations
Oliver D. Howes et al.
SCHIZOPHRENIA BULLETIN (2013)
Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes
Harry Hemingway et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Cortical Folding Defects as Markers of Poor Treatment Response in First-Episode Psychosis
Lena Palaniyappan et al.
JAMA PSYCHIATRY (2013)
Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia
Arsime Demjaha et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
Oliver D. Howes et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Increased Stress-Induced Dopamine Release in Psychosis
Romina Mizrahi et al.
BIOLOGICAL PSYCHIATRY (2012)
Metabolomic Analysis of Biochemical Changes in the Plasma and Urine of First-Episode Neuroleptic-Naive Schizophrenia Patients after Treatment with Risperidone
Hua-Lin Cai et al.
JOURNAL OF PROTEOME RESEARCH (2012)
Magnetic Resonance Imaging Predictors of Treatment Response in First-Episode Schizophrenia
Philip R. Szeszko et al.
SCHIZOPHRENIA BULLETIN (2012)
Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patients
E. Schwarz et al.
TRANSLATIONAL PSYCHIATRY (2012)
A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for Schizophrenia
Jari Tiihonen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [18F]-DOPA PET Imaging Study
Oliver D. Howes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Risperidone Nonadherence and Return of Positive Symptoms in the Early Course of Schizophrenia
Kenneth L. Subotnik et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study
O. Howes et al.
MOLECULAR PSYCHIATRY (2011)
Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
Lawrence S. Kegeles et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function
Alice Egerton et al.
NEUROIMAGE (2010)
High-dimensional pattern regression using machine learning: From medical images to continuous clinical variables
Ying Wang et al.
NEUROIMAGE (2010)
Definitions of response and remission in schizophrenia: recommendations for their use and their presentation
S. Leucht et al.
ACTA PSYCHIATRICA SCANDINAVICA (2009)
Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
Oliver D. Howes et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Mechanisms Underlying Psychosis and Antipsychotic Treatment Response in Schizophrenia: Insights from PET and SPECT Imaging
O. D. Howes et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Simple Ratio Analysis of 18F-Fluorodopa Uptake in Striatal Subregions Separates Patients with Early Parkinson Disease from Healthy Controls
Pekka Jokinen et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
Jari Tiihonen et al.
LANCET (2009)
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
Stefan Leucht et al.
LANCET (2009)
PET Studies of Cerebral Levodopa Metabolism: A Review of Clinical Findings and Modeling Approaches
Yoshitaka Kumakura et al.
NEUROSCIENTIST (2009)
The Dopamine Hypothesis of Schizophrenia: Version III - The Final Common Pathway
Oliver D. Howes et al.
SCHIZOPHRENIA BULLETIN (2009)
Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitation
Andrew Briggs et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2008)
Multi-resolution Bayesian regression in PET dynamic studies using wavelets
F. E. Turkheimer et al.
NEUROIMAGE (2006)
Remission in schizophrenia: Proposed criteria and rationale for consensus
NC Andreasen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
A prospective study of impairment in glucose control caused by clozapine without changes in insulin resistance
OD Howes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: Amphetamine-induced dopamine release in the functional subdivisions of the striatum
D Martinez et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2003)
The cost-effectiveness of clozapine: a controlled, population-based, mirror-image study
KP Hayhurst et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2002)
Management of treatment resistance in schizophrenia
RR Conley et al.
BIOLOGICAL PSYCHIATRY (2001)
Relationship between dopamine D2 occupancy, clinical response, and side effects:: A double-blind PET study of first-episode schizophrenia
S Kapur et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
分享论文
